Rejected at 10:52 p.m. Jan, 26, 2024 ] by herstein.jacob
Author: galacticescapist
Related Note: 1481335924365
Rationale for change

In the extras it says: "no "CRAB" symptoms; important distinguishing feature from multiple myeloma". This is only partly true since Waldenstrom can cause anemia (source: first aid 2023 page 436 lines 15-16: "Clinical features include anemia, constitutional (“B”) signs/symptoms, lymphadenopathy...").

Rejection reason

will use other suggestion, but going to accept

Extra Extra
Text
Does Waldenstrom macroglobulinemia present with lytic bone lesions?

{{c1::No}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy
Watch Plasma Cell Neoplasms
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review Waldenstrom Macroglobulinemia


Review Multiple Myeloma
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Plasma Cell Dyscrasias and Myeloproliferative Disease: Additional Plasma Cell Dyscrasias
OME

Additional Resources
Atlas:

Other:
One by one
Empty field
#AK_Step1_v12::#Pathoma::06_WBC::08_Plasma_Cell_(Dyscrasias) #AK_Step1_v12::#B&B::11_Hematology::03_White_Blood_Cells::05_Plasma_Cell_Disorders::Extra !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Step1_v12::#Pixorize::01_Biochemistry::19_Plasma_Cell_Dyscrasias::01_Waldenstrom_Macroglobulinemia #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::26_Plasma_cell_dyscrasias #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::18_Plasma_Cell_Dyscrasias #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step1_v12::#OME::13_Hematology_Oncology::04_Proliferation::05_Plasma_Cell_Dyscrasis #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::26_Plasma_cell_dyscrasias::02_Waldenström_macroglobulinemia #AK_Step1_v12::#Pixorize::01_Biochemistry::19_Plasma_Cell_Dyscrasias::02_Multiple_Myeloma !AK_UpdateTags::AnKing_Image::Mujeeb::Plasma_Cell_Dyscrasias #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::plasma_cell #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::01_Plasma_Cell_Disorders::Extra #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::02_Lymphoid_&_Plasma_Cell_Disorders::04_Plasma_Cell_Neoplasms #AK_Step1_v12::#USMLERx::2308.19 #AK_Step1_v12::#OME::PreClinical::13_Hematology_Oncology::04_Proliferation::05_Plasma_Cell_Dyscrasis #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::plasma_cell #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step2_v12::#AMBOSS::_t05T3 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::02_Additional_Plasma_Cell_Dyscrasias #AK_Step2_v12::#OME::05_Heme_Onc::07_Plasma_Cell